We are happy to present you our products and services.
The ROTOP trademark stands for quality and dependability. We place great emphasis on staying in close contact with our clients and on providing optimal service for the best possible individual solutions.
The following pages provide you with information about our company and our products. We are available to you at any time by phone or email for questions or if you wish to place an order. We are also happy to talk with you in person. Please inquire with our customer service department for the field manager responsible for your area.
ROTOP takes over distribution of GalliAd generator in Germany
Fleurus (Belgium), Dresden (Germany)–7th January 2021. IRE ELiT and ROTOP Pharmaka, two innovative radiopharmaceuticals companies focused on diagnostics and therapeutics announce today they have entered into an exclusive commercial agreement for the distribution of Galli Ad (the 68Ge/68Ga generator from IRE ELiT) in Germany.
This strategic decision is an important step to increase the presence of Galli Ad generators in Germany, representing the leading market in Europe for Gallium-68 development.
The switch over from distributorship will be effective early 2021, with total continuity of supply and support to our current customers. The practical modalities will be communicated to them soon.
Erich Kollegger CEO of IRE ELiT stated “We believe that there is a real and mutual interest for IRE ELiT and ROTOP to partner. The combination of our expertise and the reputation of ROTOP will work for the benefit of the patients and nuclear medicine professionals. This partnership will strengthen our position on the European market and contribute to the global development of this essential radiopharmaceutical.”
Jens Junker Managing Partner at ROTOP Pharmaka stated “We are proud to enter into the partnership with IRE ELiT, one of the leading European radiopharmaceutical companies, which is driving innovation for the benefit of patients and nuclear medicine. With the Galli Ad generators ROTOP enhances its portfolio of radiopharmaceuticals in Germany and continues the strategy of offering a wide range of radiopharmaceuticals.”
Download: Press Release
ROTOP Pharmaka has taken appropriate measures in order to be able to guarantee production and delivery capability over a longer period of time. The situation is continuously monitored by our crisis management team. Further measures will be taken, if necessary.
OUR CUSTOMER SERVICE
+49 (0) 351 - 26 310 210
+49 (0) 351 - 26 310 313
|Mo - Thu||07:00 am - 05:00 pm|
|Fr||07:00 am - 04:00 pm|